Mission BioCapital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
12

- Investments
-
115
- Portfolio
-
60
- Exits
-
32

Mission BioCapital General Information
Company Description
Founded in 2009, Mission Biocapital is a venture capital firm based in Cambridge, Massachusetts. The firm seeks to invest in early-stage companies operating in the life science and biotechnology sectors. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.missionbiocapital.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- 139 Main Street
- Suite 401
- Cambridge, MA 02142
- United States
Mission BioCapital Investments (115)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Bullseye Bio | 31-Jan-2025 | Early Stage VC | Pharmaceuticals | Startup | ||
Circle Pharma | 10-Jan-2025 | Drug Discovery | Clinical Trials - Phase 1 | |||
March Biosciences | 03-Jan-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
D2B3 | 01-Jan-2025 | Biotechnology | Pre-Clinical Trials | |||
Merge Therapeutics | 01-Jan-2025 | Other Pharmaceuticals and Biotechnology | Stealth | |||
SiteOne Therapeutics | 18-Dec-2024 | Drug Discovery | Generating Revenue | |||
Alessa Therapeutics | 13-Dec-2024 | Drug Delivery | Clinical Trials - Phase 1 | |||
Nuvig Therapeutics | 05-Dec-2024 | Drug Discovery | Generating Revenue | |||
Cloverleaf Bio | 30-Oct-2024 | Accelerator/Incubator | Biotechnology | Pre-Clinical Trials | ||
NuCyRNA Therapeutics | 30-Oct-2024 | Seed Round | Drug Discovery | Generating Revenue |
Mission BioCapital Exits (32)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Bolt Threads | 13-Aug-2024 | Reverse Merger | |
Mitokinin | 04-Oct-2023 | ||
Fluxion (Diagnostic Equipment) | 23-Aug-2023 | ||
Cereius | 22-Jun-2023 | ||
Cellanyx | 01-Jun-2023 | ||
Pionyr Immunotherapeutics | 01-Apr-2023 | ||
Vedere Bio II | 31-Mar-2023 | ||
ViewPoint Therapeutics | 28-Jul-2022 | ||
Veritas (Laboratory Services) | 29-Mar-2022 | Merger/Acquisition | |
Comet Therapeutics | 21-Sep-2021 | Merger/Acquisition |
Mission BioCapital Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
Mission BioCapital Investments by Industry, Year, and Region
Mission BioCapital Co-Investors (187)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Alexandria Venture Investments | 5 |
![]() |
![]() |
||
Mission Bay Capital |
![]() |
![]() |
|||
Bristol-Myers Squibb |
![]() |
![]() |
|||
Eli Lilly and Company |
![]() |
![]() |
|||
Novo Holdings |
![]() |
![]() |
Mission BioCapital FAQs
-
What is Mission BioCapital?
Founded in 2009, Mission Biocapital is a venture capital firm based in Cambridge, Massachusetts.
-
When was Mission BioCapital founded?
Mission BioCapital was founded in 2009.
-
Where is Mission BioCapital headquartered?
Mission BioCapital is headquartered in Cambridge, MA.
-
What is Mission BioCapital's total asset value?
Mission BioCapital has around
in total assets under management. -
How many investments has Mission BioCapital made?
Mission BioCapital has made 115 investments.
-
What has Mission BioCapital invested in?
Mission BioCapital has made numerous investments in companies like Bullseye Bio, Circle Pharma, and March Biosciences within the Pharmaceuticals and Drug Discovery industries.
-
What has Mission BioCapital invested in recently?
Mission BioCapital's latest investment was on 31-Jan-2025 in Bullseye Bio, a company within the Pharmaceuticals industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »